The basis for sex differences in CFTR correction with ETI therapy and uncoupling from pulmonary function remain unexplained but may be due to greater CFTR modulator effects on ASL dynamics and mucociliary clearance in male CF patients. Here, CFTR is linked to cystic fibrosis.